文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

急性症状性低钠血症:3%高渗盐水20分钟快速间断推注对比3小时持续输注

Rapid bolus versus 3-h continuous infusion of 3% hypertonic saline for acute symptomatic hyponatremia.
PubMed 文献 · Am J Emerg Med · 2026-10-14
一句话结论急诊急性症状性低钠血症用3%高渗盐水RIB(20 min)或SCI(3 h)24小时血钠纠正相近且不良事件少,但SCI组30天低钠相关再入院率更高,需更大研究确认。

这项前瞻性队列研究纳入58例急诊急性症状性低钠血症成人,按研究专用分配表分为3%高渗盐水20分钟快速间断推注组(RIB,n=29)和3小时缓慢持续输注组(SCI,n=29)。两组24小时血钠纠正幅度相近;SCI组出现1例过度纠正,未发生渗透性脱髓鞘综合征。30天低钠血症相关再入院率RIB组为13.8%,SCI组为41.4%(p=0.019);探索性校正分析中SCI组再入院aOR为7.04(95%CI 1.56-31.80,p=0.011)。

要点

  • 急诊急性症状性低钠血症成人中,3%高渗盐水RIB(20 min)与SCI(3 h)的24小时血钠纠正幅度相近。
  • 本研究SCI组30天低钠血症相关再入院率为41.4%,RIB组为13.8%(p=0.019);探索性校正分析SCI组aOR为7.04(95%CI 1.56-31.80,p=0.011)。
  • 本研究SCI组出现1例过度纠正,未发生渗透性脱髓鞘综合征;两组不良事件总体较少。
  • 探索性分析显示基线GCS评分较高与30天全因死亡较低相关(aOR 0.39;95%CI 0.17-0.88;p=0.025)。
  • 探索性ROC分析显示基线血钠≤115.5 mmol/L对需要第二剂高渗盐水的区分度AUC为0.754。

适用人群与场景

  • 急诊科就诊的急性症状性低钠血症成人患者。
  • 共58例成人,RIB组29例,SCI组29例。

诊断标准与关键阈值

  • 基线血钠≤115.5 mmol/L为探索性阈值,对第二剂高渗盐水需求有区分能力,AUC为0.754。
  • 原文未报告急性症状性低钠血症的具体诊断标准名称及纳入、排除界值。

处置流程与药物剂量

  • RIB方案:3%高渗盐水20分钟快速间断推注。
  • SCI方案:3%高渗盐水3小时缓慢持续输注。
  • 原文未报告两组3%高渗盐水的具体剂量、单位、频次及目标血钠等实施细节。

红旗征与不能漏的情况

  • 本研究SCI组发生1例过度纠正,未发生渗透性脱髓鞘综合征。
  • 原文未报告渗透性脱髓鞘综合征以外的其他需紧急处理的红旗征。

研究设计与关键结果

  • 前瞻性队列研究,纳入58例急诊急性症状性低钠血症成人,按研究专用分配表分为RIB组(n=29)和SCI组(n=29)。
  • 主要结果:两组24小时血钠纠正幅度相近。
  • 30天低钠血症相关再入院率RIB组13.8%,SCI组41.4%(p=0.019)。
  • 探索性校正分析:SCI组30天低钠血症相关再入院aOR为7.04(95%CI 1.56-31.80;p=0.011)。
  • 探索性分析:基线GCS评分较高与30天全因死亡较低相关(aOR 0.39;95%CI 0.17-0.88;p=0.025)。
  • 探索性ROC分析:基线血钠≤115.5 mmol/L对第二剂需求AUC为0.754。

证据类型、等级与局限

  • 证据类型:前瞻性队列研究。
  • 局限:非随机、采用研究专用分配表分组、样本量小、单中心,原文明确提出30天再入院差异及基线神经状态和血钠相关探索性关联需更大研究确认。

对床旁实践的改变

  • 在急诊急性症状性低钠血症成人中,3%高渗盐水RIB(20 min)与SCI(3 h)短期内纠正血钠效果相近,提示两种方案在紧急纠正阶段可能均为可选。
  • 本研究观察到SCI组30天低钠血症相关再入院率更高,但原文强调该差异及探索性关联尚需更大研究确认,不能据此单独改变临床方案。
  • 原文未提供药物具体剂量、频次和目标值,床旁实施时不能将本研究方案直接作为剂量推荐。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND AND OBJECTIVES: Hyponatremia is a common electrolyte disorder in emergency care that requires careful clinical management. Sodium correction, safety, 30-day hyponatremia-related hospital readmission, and mortality were compared between a 20-min rapid intermittent bolus (RIB) and a 3-h slow continuous infusion (SCI) of 3% hypertonic saline in adults with acute symptomatic hyponatremia.

METHODS: This prospective cohort study included 58 adults presenting to the emergency department with acute symptomatic hyponatremia patients were assigned to RIB (20 min; n = 29) or SCI (3 h; n = 29) using a study-specific allocation list. Sodium kinetics through 24 h, safety, and 30-day outcomes were assessed using ANCOVA, repeated-measures ANOVA, multivariable regression, and ROC analysis.

RESULTS: Twenty-four-hour sodium correction was comparable between groups. One overcorrection occurred with SCI; no osmotic demyelination syndrome occurred. Thirty-day hyponatremia-related hospital readmission was 13.8% with RIB and 41.4% with SCI (p = 0.019); In an exploratory adjusted analysis, SCI was associated with higher adjusted odds (aOR) of readmission (aOR:7.04; 95% confidence interval [CI], 1.56-31.80; p = 0.011). Higher baseline Glasgow Coma Scale score was associated with lower 30-day-all-cause mortality (aOR, 0.39; 95% CI, 0.17-0.88; p = 0.025). A baseline sodium cutoff of ≤115.5 mmol/L showed exploratory discrimination for second dose requirement with an area under the curve of 0.754.

CONCLUSION: Both RIB and SCI protocols demonstrated similar short-term sodium correction, with few observed adverse events. The difference in 30-day hyponatremia-related hospital readmission and exploratory associations involving baseline neurological status and serum sodium require confirmation in larger studies.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Şafak, Şirin. Rapid bolus versus 3-h continuous infusion of 3% hypertonic saline for acute symptomatic hyponatremia. Am J Emerg Med. 2026. PMID: 42913073. doi:10.1016/j.ajem.2026.10.010

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。